Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(JAGSNPHARM) Jagsonpal Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jagsonpal Pharmaceuticals | (JAGSNPHARM) share price targets

Complete technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM) by charts plus indicators, forecast predictions and share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Jagsonpal Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2024-06-19 View latest technical analysis

10 day averaged volume of Jagsonpal Pharmaceuticals is 29979

Date	Daily Closing Price	Open	High	Low	Volume
19 Wed Jun 2024	339.55	341.05	347.25	336.30	2.527 times
18 Tue Jun 2024	340.45	344.35	347.20	338.05	0.965 times
14 Fri Jun 2024	344.20	341.75	347.00	341.10	1.393 times
13 Thu Jun 2024	341.75	341.80	345.90	340.60	0.582 times
12 Wed Jun 2024	340.95	335.80	346.95	335.00	0.843 times
11 Tue Jun 2024	334.70	337.55	342.70	330.90	0.479 times
10 Mon Jun 2024	337.70	340.00	345.15	335.15	0.527 times
07 Fri Jun 2024	335.10	333.25	345.45	332.95	1.209 times
06 Thu Jun 2024	328.40	327.00	340.00	321.40	1.053 times
05 Wed Jun 2024	326.25	300.40	329.00	292.10	1.485 times

Stock of Jagsonpal Pharmaceuticals (JAGSNPHARM) has showed a significant fall. This could be a good time to exit from this stock.

My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 344.1 as stoploss in an intra day sell trade for a target of 334.31. However, stock will show a bullish move above 344.1.

Share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Target Type	Value
Downside Target	273.60
Downside Target	288.00
Downside Target	312.15
Downside Target	329.90
Upside Target	345.45
Upside Target	347.25
Upside Target	347.50
Upside Target	354.80
Upside Target	372.90
Upside Target	375.50
Upside Target	387.80

Intraday share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Target Type	Value
Downside Intraday Target	334.82
Downside Intraday Target	330.08
Upside Intraday Target	345.77
Upside Intraday Target	351.98
Upside Intraday Target	341.03

Weekly technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Date	Weekly Closing Price	Open	High	Low	Volume
19 Wed Jun 2024	339.55	344.35	347.25	336.30	0.913 times
14 Fri Jun 2024	344.20	340.00	347.00	330.90	0.649 times
07 Fri Jun 2024	335.10	332.60	345.45	275.00	1.168 times
31 Fri May 2024	326.10	343.50	347.50	317.50	0.985 times
24 Fri May 2024	342.15	354.80	354.80	329.90	0.417 times

Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Date	Monthly Closing Price	Open	High	Low	Volume
19 Wed Jun 2024	339.55	332.60	347.25	275.00	0.462 times
31 Fri May 2024	326.10	363.90	375.50	314.95	0.89 times
30 Tue Apr 2024	361.55	280.65	372.90	278.70	2.037 times
28 Thu Mar 2024	276.60	299.45	312.15	273.60	0.318 times

Scroll below to view daily charts

Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Jagsonpal Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Jagsonpal Pharmaceuticals in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Jagsonpal Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Jagsonpal Pharmaceuticals in short term but SELL signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Jagsonpal Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 336.81 and Jagsonpal Pharmaceuticals (JAGSNPHARM) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Jagsonpal Pharmaceuticals (JAGSNPHARM) stock. Volume based technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM) stock is negative.

Jagsonpal Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.